Works matching IS 08876924 AND DT 2005 AND VI 19 AND IP 12

Results: 54
    1
    2
    3
    4
    5
    6
    7

    Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit – multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group

    Published in:
    Leukemia (08876924), 2005, v. 19, n. 12, p. 2082, doi. 10.1038/sj.leu.2403867
    By:
    • Perel, Y.;
    • Auvrignon, A.;
    • Leblanc, T.;
    • Michel, G.;
    • Reguerre, Y.;
    • Vannier, J.-P.;
    • Dalle, J.-H.;
    • Gandemer, V.;
    • Schmitt, C.;
    • Méchinaud, F;
    • Lejars, O;
    • Piguet, C;
    • Couillaud, G;
    • Pautard, B;
    • Landman-Parker, J;
    • Thuret, I;
    • Aladjidi, N;
    • Baruchel, A;
    • Leverger, G
    Publication type:
    Article
    8

    Reply to van der Sluijs-Gelling et al.

    Published in:
    Leukemia (08876924), 2005, v. 19, n. 12, p. 2351, doi. 10.1038/sj.leu.2403912
    By:
    • Gaipa, G.;
    • Basso, G.;
    • Ratei, R.;
    • Biondi, A.;
    • Dworzak, M.
    Publication type:
    Article
    9
    10
    11
    12
    13

    Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report.

    Published in:
    Leukemia (08876924), 2005, v. 19, n. 12, p. 2072, doi. 10.1038/sj.leu.2403932
    By:
    • Entz-Werle, N.;
    • Suciu, S.;
    • van der Werff ten Bosch, J.;
    • Vilmer, E.;
    • Bertrand, Y.;
    • Benoit, Y.;
    • Margueritte, G.;
    • Plouvier, E.;
    • Boutard, P.;
    • Vandecruys, E.;
    • Ferster, A.;
    • Lutz, P.;
    • Uyttebroeck, A.;
    • Hoyoux, C.;
    • Thyss, A.;
    • Rialland, X.;
    • Norton, L.;
    • Pages, M.-P.;
    • Philippe, N.;
    • Otten, J.
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).

    Published in:
    Leukemia (08876924), 2005, v. 19, n. 12, p. 2223, doi. 10.1038/sj.leu.2403963
    By:
    • Germing, U.;
    • Hildebrandt, B.;
    • Pfeilstöcker, M.;
    • Nösslinger, T.;
    • Valent, P.;
    • Fonatsch, C.;
    • Lübbert, M.;
    • Haase, D.;
    • Steidl, C.;
    • Krieger, O.;
    • Stauder, R.;
    • Giagounidis, A.A.N.;
    • Strupp, C.;
    • Kündgen, A.;
    • Mueller, T.;
    • Haas, R.;
    • Gattermann, N.;
    • Aul, C.
    Publication type:
    Article
    26
    27
    28

    Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)

    Published in:
    Leukemia (08876924), 2005, v. 19, n. 12, p. 2304, doi. 10.1038/sj.leu.2403967
    By:
    • Aoudjhane, M.;
    • Labopin, M.;
    • Gorin, N.C.;
    • Shimoni, A.;
    • Ruutu, T.;
    • Kolb, H.-J.;
    • Frassoni, F.;
    • Boiron, J.M.;
    • Yin, J.L.;
    • Finke, J.;
    • Shouten, H.;
    • Blaise, D.;
    • Falda, M.;
    • Fauser, A.A.;
    • Esteve, J.;
    • Polge, E.;
    • Slavin, S.;
    • Niederwieser, D.;
    • Nagler, A.;
    • Rocha, V.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50